Nordson Corporation · NASDAQ:NDSN
Nordson — Q2 2022 Earnings Presentation
14 slides from Nordson's earnings presentation, May 24, 2022
Slide 1: 2Q Fiscal 2022 Webcast
2Q Fiscal 2022 Webcast May 24, 2022 NBS NEXT OWNER MINDSET WINNING TEAMS
Slide 2: Safe Harbor Statement
Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by
Slide 3: Agenda
Agenda 2Q Fiscal 2022 Webcast – May 24, 2022 Second Quarter Highlights Sales Performance and Earnings Review Balance Sheet and Cash Flow Enterprise Performance 3Q 2022 and FY 2022 Guidance Q&A Sundaram Nagarajan Joseph Kelley Lara Mahoney President and Executive Vice President, Vice Pres
Slide 4: Q2 2022 Highlights
Q2 2022 Highlights • Order entry remains robust with a favorable second quarter book-to- bill ratio Strong sales and earnings growth with NBS Next execution • Deploying the NBS Next growth framework • The Nordson Impact, our investment in the communities, remains strong 4
Slide 5: Total Company – 2Q 2022
Total Company – 2Q 2022 2Q 2022 Sales Bridge Sales Reported sales increased 8% $21 7% organic growth; 4% acquisitive growth; (3)% currency impact Organic sales increase was driven by strong demand across most end markets. Growth was negatively impacted by ~$20 million related to China COVID 2Q
Slide 6: Industrial Precision Solutions – 2Q 2022
Industrial Precision Solutions – 2Q 2022 2Q 2022 IPS Sales Bridge Sales 6% sales increase, despite currency headwinds of 4% China COVID lockdowns negatively impacted sales ~$15 million Organic growth was driven by polymer processing product lines, plus steady growth in consumer non- durables 2
Slide 7: Advanced Technology Solutions – 2Q 2022
Advanced Technology Solutions – 2Q 2022 2Q 2022 ATS Sales Bridge Sales Sales increased 10%, to a record $319 million 11% organic growth; (2)% currency impact Growth was across most major product lines, particularly in electronics dispense, test and inspection and biopharma fluid component prod
Slide 8: Balance Sheet and Cash Flow
Balance Sheet and Cash Flow Strong Cash Flow with Sufficient Liquidity to Invest in Strategic Initiatives Net Debt Free Cash Flow Cash totaled $121 million Strategic investments in inventory to address supply chain constraints and support growth 0.9 net debt leverage ratio based on trailing 12
Slide 9: Enterprise Highlights
Enterprise Highlights Accelerating NBS Next deployment End market demand remains strong Record growth in ATS Segment • Launched NBS Next Accelerator • Growth drivers remain strong in • Customer trends drive growth: Training medical and electronics end markets expanding capacity, onshoring, • Real No
Slide 10: 3Q Fiscal 2022 Guidance
3Q Fiscal 2022 Guidance 3Q 2022 Sales Guidance Steady Growth 3Q 2022 Sales Guidance $647 $640 - $655 Order entry remains strong in Q2 with a favorable book-to-bill ratio $538 Backlog over $1 billion related to extended shipment dates for large orders in electronics, industrial and medical end ma
Slide 11: Full-Year Fiscal 2022 Guidance
Full-Year Fiscal 2022 Guidance Full-Year Sales Guidance Full-Year Growth from Record 2021 $2,551 - $2,575 $2,563 $2,362 Fiscal 2022 sales growth of ~8-9% $2,121 Raising previously issued year-over-year adjusted earnings growth to ~18-21%. Strong sales and earnings growth against record year is
Slide 12: Questions?
Questions? Giordson
Slide 13: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 13
Slide 14: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 14